Speaker illustration

Doctor Joanna Zakrzewska-Koperska

Institute of Cardiology, Warsaw (Poland)

Differences in response to treatment with a sodium channel antagonists in arrhythmic DCM caused by the SCN5A R222Q versus R814W variant

Event: Heart Failure 2024

Topic: Clinical

Session: ePosters in arrhythmias and device therapy 7

Thumbnail

Successful antiarrhythmic therapy with combination of quinidine and mexiletine in Purkinje-related ventricular arrhythmia, persistent atrial tachyarrhythmia and DCM associated with R814W SCN5Amutation

Event: Heart Failure 2019

Topic: Treatment

Session: Clinical Cases

Thumbnail